Luis Madeira

Prof. Dr. Luis Madeira


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2018 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
LSLouis Sass
Louis Sass
JBJuan P Borda
Juan P Borda
LMLuis Madeira
Luis Madeira
EPElizabeth Pienkos
Elizabeth Pienkos
BNBarnaby Nelson
Barnaby Nelson
The self-disorder model offers a unifying way of conceptualizing schizophrenia’s highly diverse symptoms (positive, negative, disorganized), of capturing their distinctive bizarreness, and of conceiving their longitudinal development. These symptoms are viewed as differing manifestations of an underlying disorder of ipseity or core-self: hyper-reflexivity/diminished-self-presence with accompanying disturbances of “grip” or “hold” on reality. Recent revision to this phenomenological theory, in particular distinguishing primary-vs-secondary factors, offers a bio-pheno-social model that is consistent with recent empirical findings and offers several advantages: (1) It helps account for the temporal variations of the symptoms or syndrome, including longitudinal progression, but also the shorter-term, situationally reactive, and sometimes defensive or quasi-intentional variability of symptom-expression that can occur in schizophrenia (consistent with understanding some aspects of ipseity-disturbance as dynamic and mutable, involving shifting attitudes or experiential orientations). (2) It accommodates the overlapping of some key schizophrenic symptoms with certain nonschizophrenic conditions involving dissociation (depersonalization, derealization), including depersonalization disorder and panic disorder, thereby acknowledging both shared and distinguishing symptoms. (3) It integrates recent neurocognitive and neurobiological as well as psychosocial (eg, influence of trauma and culture) findings into a coherent but multi-factorial neuropsychological account. An adequate model of schizophrenia will postulate shared disturbances of core-self experiences that nevertheless can follow several distinct pathways and occur in various forms. Such a model is preferable to uni-dimensional alternatives—whether of schizophrenia or ipseity-disturbance—given its ability to account for distinctive yet varying experiential and neurocognitive abnormalities found in research on schizophrenia, and to integrate these with recent psychosocial and neurobiological findings.

1 April 2016 in Comprehensive Psychiatry
Verified
Journal Article
Closed access
LMLuis Madeira
Luis Madeira
IBIlaria Bonoldi
Ilaria Bonoldi
MRMatteo Rocchetti
Matteo Rocchetti
CSCarly Samson
Carly Samson
MAMatilda Azis
Matilda Azis
GSGiovanni Stanghellini
Giovanni Stanghellini

13 November 2019 in Psychopathology
Verified
Journal Article
Open access
PDF file
LMLuis Madeira
Luis Madeira
BLBeatriz Leal
Beatriz Leal
TFTeresa Filipe
Teresa Filipe
MRMadalena Ferro Rodrigues
Madalena Ferro Rodrigues
MFMaria Luísa Figueira
Maria Luísa Figueira
The illness experience encompasses not only several changes in bodily processes but also the very feeling of becoming ill. This seemingly non-scientific aspect of being sick is characterized by forms of uncanny body experiences and an unhomelike being-in-the-world. Both include disconcerting phenomena, feelings of fear, restlessness, and inexplicability. In this paper we discuss some contributions aiming to understand the illness experience, focusing on the concept of the uncanny. This life event brings changes in the familiarity of our world, revelation of what previously was and should have remained hidden, loss of control, and the certainty of mortality. The experience of uncanniness is here conceptualized as a psychopathological phenomenon that should be regarded as a general symptom of diseases and should be identified and approached. We discuss the impact of these considerations on medical practice, focusing on the role of physicians and ultimately on the purpose of medicine.

1 September 2019 in Schizophrenia Research
Verified
Journal Article
Closed access
LMLuis Madeira
Luis Madeira
EPElizabeth Pienkos
Elizabeth Pienkos
TFTeresa Filipe
Teresa Filipe
MMMariana Melo
Mariana Melo
GQGuilherme Queiroz
Guilherme Queiroz
LSLouis Sass
Louis Sass

24 August 2023 in Philosophies
Verified
Journal Article
Open access
PDF file
NANuno Azevedo
Nuno Azevedo
MSMiguel Oliveira Da Silva
Miguel Oliveira Da Silva
LMLuis Madeira
Luis Madeira
Background: Psychedelics are known for their powerful mental effects due to the activation of 5HT-2A receptors in the brain. During the 1950s and 1960s, research was conducted on these molecules until their criminalization. However, their clinical investigation as therapeutic tools for psychiatric disorders has revived the deontological ethics surrounding this subject. Questions arise as research on their therapeutic outcome becomes a reality. We aim to explore deontological ethics to understand the implications of psychedelics for the clinician, patient, and society. Results: A total of 42 articles were considered for this review. Methods: A methodological search of psychedelic studies from 2017 to 2022 was conducted in PubMed, Scopus, EBSCOhost, and ScienceDirect to address the deontological ethics of clinical psychedelic use. Conclusion: Psychedelics need to be culturally contextualized, epistemic harm minimized and represented to ensure informed consent. Open data and commissions are needed to ensure safe and equal distribution.

10 May 2019 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
IBIlaria Bonoldi
Ilaria Bonoldi
PAPaul Allen
Paul Allen
LMLuis Madeira
Luis Madeira
STStefania Tognin
Stefania Tognin
MBMatthijs G. Bossong
Matthijs G. Bossong
PMPhilip McGuire
Philip McGuire
Introduction: Alterations of the “pre-reflective” sense of first-person perspective (e.g., of the “basic self”) are characteristic features of schizophrenic spectrum disorders and are significantly present in the prodromal phase of psychosis and in subjects at ultrahigh risk for psychosis (UHR). Studies in healthy controls suggest that neurobiological substrate of the basic self involves cortical midline structures, such as the anterior and posterior cingulate cortices. Neuroimaging studies have identified neuroanatomical cortical midline structure abnormalities in schizophrenic spectrum disorders. Objectives: i) To compare basic self-disturbances levels in UHR subjects and controls and ii) to assess the relationship between basic self-disturbances and alterations in cortical midline structures volume in UHR subjects. Methods: Thirty-one UHR subjects (27 antipsychotic-naïve) and 16 healthy controls were assessed using the 57-item semistructured Examination of Anomalous Self-Experiences (EASE) interview. All subjects were scanned using magnetic resonance imaging (MRI) at 3 T, and gray matter volume was measured in a priori defined regions of interest (ROIs) in the cortical midline structures. Results: EASE scores were much higher in UHR subjects than controls (p < 0.001). The UHR group had smaller anterior cingulate volume than controls (p = 0.037). There were no structural brain imaging alterations between UHR individuals with or without self-disturbances. Within the UHR sample, the subgroup with higher EASE scores had smaller anterior cingulate volumes than UHR subjects with lower EASE scores and controls (p = 0.018). In the total sample, anterior cingulate volume was inversely correlated with the EASE score (R = 0.52, p < 0.016). Conclusions: Basic self-disturbances in UHR subjects appear to be related to reductions in anterior cingulate volume.